About Paragon 28
Paragon 28 is a Healthcare company based in Englewood (United States) founded in 2010 by Jim Riegler and Lee Rosenthal, and was acquired by Zimmer Biomet in January 2025. Devices for foot and ankle surgical procedures are provided. Paragon 28 has raised $200 thousand across 3 funding rounds from investors including MidCap Financial, Zimmer Biomet and MVM Partners. The company has 574 employees. Paragon 28 has completed 2 acquisitions, including Additive Orthopaedics and Disior. Its website paragon28.com draws about 15 thousand monthly visits. Paragon 28 offers products and services including Gorilla® Plating System, Phantom® MIS System, SMART28℠, and Silverback™ Plating System. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is PARAGON 28, INC. Its competitors include Biomet, Treace Medical Concepts and IlluminOss Medical; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2010 and based in Englewood, United States, orthopedic devices for foot and ankle surgery are developed and supplied. Products encompass forefoot and hindfoot plating systems, medical screws, allograft bone options, and specialized instruments. The portfolio features Gorilla plating solutions, screw systems, and custom bone wedges, supporting surgical applications in the medical device sector.
- Headquarters Englewood, United States
- Employees 574
- Founders Jim Riegler, Lee Rosenthal
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website paragon28.com
- Social LinkedIn X Facebook Instagram
- Acquired by Zimmer Biomet (Jan 2025)
- Legal Name Paragon 28, Inc.
- Annual Revenue$44.04 M (USD)-76as on Dec 31, 2024
- Net Profit-$54.64 M (USD)5as on Dec 31, 2024
- EBITDA-$40.78 M (USD)11as on Dec 31, 2024
- Total Equity Funding$200K (USD)
in 3 rounds
- Latest Funding Round$70M (USD), Debt – Conventional
Jun 2021
- InvestorsMidCap Financial
& 2 more
- Employee Count574
- Investments & AcquisitionsAdditive Orthopaedics
& 1 more
- Acquired byZimmer Biomet
(Jan 2025)
Products & Services of Paragon 28
Paragon 28 offers a comprehensive portfolio of products and services, including Gorilla® Plating System, Phantom® MIS System, SMART28℠, and Silverback™ Plating System.
System for treating ankle and calcaneal fractures
Minimally invasive tool for bunion and deformity correction
Platform for data-driven foot and ankle treatment planning
Plating for ankle fusion and related procedures
Funding Insights of Paragon 28
Paragon 28 has successfully raised a total of $200K across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $70 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $200,000
- Total Rounds 3
- Last Round Debt – Conventional — $70M
- First Round $200,000
(Nov 2011)
- Investors Count 2
All 3 funding rounds of Paragon 28 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $70M | Debt – Conventional | – | – | |
| Aug 2020 | Series B | – | MVM | – | |
| Nov 2011 | $200,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Paragon 28
Paragon 28 has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include MidCap Financial, Zimmer Biomet and MVM Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt funds are managed across multiple sectors. | 2008 | midcapfinancial.com | Bethesda, United States | |
Private equity investments in healthcare companies are managed. | 1997 | mvm.com | London, United Kingdom | |
Medical devices for multiple health purposes are manufactured. | 1927 | zimmerbiomet.com | Warsaw, United States |
Investor details for Paragon 28
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Paragon 28
39 people are tracked at Paragon 28 (17 in leadership, 6 in board & advisors, 16 in team); the tracked headcount is 574.
| Name | Role | Group |
|---|---|---|
Jim Riegler | Co-Founder | Leadership |
Lee Rosenthal | Co-Founder | Leadership |
Luis Antonio | Area Vice President - APAC | Leadership |
Jim Edson | Vice President of Downstream Marketing | Leadership |
Albert DaCosta | Co-Founder, President & CEO | Leadership |
Michelle Missal | VP & Chief Compliance Officer | Leadership |
Greg Kowalczyk | VP, Patient Specific | Leadership |
Carissa Kennison | Director Of Marketing - Patient Specific | Leadership |
Yuliya Aslan | VP, IT | Leadership |
Matthew Millard | Chief Human Resources Officer | Leadership |
Phillip Falcon | Sales Director | Leadership |
Tom Moorcroft | Area Vice President - Emeac | Leadership |
Relene Harmon | Senior Director Of Compliance | Leadership |
Scott Westerhold | Director Of Sales - East Great Lakes | Leadership |
Adam Yoder | Director Of Sales - Midwest U.s. | Leadership |
Nick Sorensen | Director Of Biologics | Leadership |
Calvin Ward | VP Ops | Leadership |
Meghan Scanlon | Director | Board & advisors |
Krissy Wright | Director | Board & advisors |
Stephen Oesterle | Director | Board & advisors |
19 more people are available in the full profile.
Complete people profiles for Paragon 28
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paragon 28
Paragon 28 has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Additive Orthopaedics and Disior.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bone fracture analysis and treatment planning software is developed. | disior.com | Espoo, Finland | 2016 | Jan 2022 | $18M | |
Orthopedic devices and implants are developed using 3D printing technology. | additiveorthopaedics.com | New York, United States | 2015 | Jun 2021 | •••• |
Complete acquisition details for Paragon 28
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Paragon 28
7 dated milestones of Paragon 28 across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Paragon 28 is founded.
- Funding First funding round of $200K.
- Acquisition Acquires Additive Orthopaedics.
- Funding Latest funding round, Debt – Conventional, of $70.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Disior.
- Exit Acquired by Zimmer Biomet.
Competitors of Paragon 28
Paragon 28 has 3 listed competitors in our database, 2 of them funded. They include Biomet, Treace Medical Concepts and IlluminOss Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biomet.com | 1977 | Warsaw, United States | 3,664 | Orthopedic surgical and non-surgical products are designed and distributed. | ||
| treace.com | 2013 | Ponte Vedra Beach, United States | $15M | 516 | Orthopedic foot and ankle correction systems are developed and offered. | |
| illuminoss.com | 2007 | East Providence, United States | $62.47M | 21 | Minimally invasive orthopedic systems for bone fracture stabilization are developed. |
Detailed competitors of Paragon 28
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Paragon 28
The website of Paragon 28 (paragon28.com) receives about 15.3K visits a month.
- Monthly visits15.3K
▼ 10.7% vs previous month
Websites whose visitors overlap most with Paragon 28. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
odtmag.com | odtmag.com | 100% | #1,737,178 | – | |
wheelessonline.com | wheelessonline.com | 95% | #306,992 | – | |
| stryker.com | 95% | 1.1M | #56,352 | View details | |
medtechdive.com | medtechdive.com | 95% | #345,845 | – | |
podiatryinstitute.com | podiatryinstitute.com | 74% | #1,432,628 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Paragon 28
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Paragon 28 (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Paragon 28
Complete news archive for Paragon 28
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragon 28
Paragon 28 was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Paragon 28 is headquartered in Englewood, United States. It is registered at Englewood, New Jersey, United States.
Paragon 28 is a funded company, having raised a total of $200K across 3 funding rounds to date. The company's 1st funding round was a Seed of $200K, raised on Nov 2011.
Paragon 28 has 574 employees.
Annual revenue of Paragon 28 is $44.04M as on Dec 31, 2024.
Founded in 2010 and based in Englewood, United States, orthopedic devices for foot and ankle surgery are developed and supplied. Products encompass forefoot and hindfoot plating systems, medical screws, allograft bone options, and specialized instruments. The portfolio features Gorilla plating solutions, screw systems, and custom bone wedges, supporting surgical applications in the medical device sector.
Paragon 28's top competitors include Treace Medical Concepts, IlluminOss Medical and Biomet.
Paragon 28 offers Gorilla® Plating System, Phantom® MIS System, SMART28℠, and Silverback™ Plating System.
Paragon 28 has made 2 acquisitions, including Additive Orthopaedics, and Disior.
Paragon 28 has 3 investors. Key investors include MidCap Financial, Zimmer Biomet, and MVM Partners.
Paragon 28 operates through Paragon 28, Inc..
Yes. Paragon 28 was acquired by Zimmer Biomet in January 2025.